1
Q
DBLC LN pattern
A
- diffuse
2
Q
acute lymphoblastic curable
A
- yes
3
Q
ALL treatment
A
- combination chemo
4
Q
acute lymphoblastic working formulation grade
A
- high
5
Q
CML peripheral smear
A
- meyloid - left shifted - predominately mature
6
Q
acute lymphoblastic cytogenetic abnormality
A
- none
7
Q
Burkitt working formulation grade
A
- high
8
Q
Burkitt curable
A
- yes
9
Q
mantle cell immunostain
A
- cyclin D1
10
Q
ALL adverse prognostic features
A
- Ph+ - age - t(4;11) - hypodiploidy
11
Q
follicular immunostain
A
- BCL2
12
Q
SLL LN pattern
A
- diffuse
13
Q
CLL flow
A
- CD5/CD23
14
Q
Burkitt LN pattern
A
- starry sky
15
Q
mantle cell flow
A
- CD5+ - CD19+ - CD23- - clonal
16
Q
CML flow
A
- no clonal lymphoid population
17
Q
mantle cell cytogenetic abnormality
A
- t(11;14)
18
Q
mantle cell LN pattern
A
- starry sky
19
Q
APML cytogenetic abnormality
A
- t(15;17)
20
Q
CLL adverse prognostic features
A
- cytogenetics - autoimmunity
21
Q
ALL curable
A
- yes
22
Q
ALL peripheral smear
A
- blasts
23
Q
hodgkin immunostain
A
- CD15/CD30
24
Q
follicular most diagnostic test
A
- flow - cytogenetics
25
Burkitt immunostain
- none
26
AML curable
- yes
27
CLL peripheral smear
- mature lymphoid cells - smudge cells
28
DBLC cytogenetic abnormality
- none
29
CLL curable
- no
30
follicular flow
- CD10+ - CD19+ - clonal
31
AML flow
- CD34+ - HLA-DR+
32
ALL flow
- CD34+ - CD10/19/Tdt
33
DBLC curable
- yes
34
AML treatment
- 7+3
35
hodgkin working formulation grade
- intermediate
36
burkitt most diagnostic test
- cytogenetics
37
SLL most diagnostic test
- flow
38
mantle cel curable
- no
39
SLL cytogenetic abnormality
- no
40
SLL curable
- no
41
Burkitt cytogenetic abnormality
- t(8;14) - t(2;8) - t(8;22)
42
CML treatment
- imatininb
43
mantle cell most diagnostic test
- flow - cytogenetics
44
AML adverse prognostic features
- Ph+ - age - arising from MDS or MPN or prior chemo - multiple cytogenetic abnormalities
45
APML flow
- CD 34 neg - HLA-DR neg - CD13+ - CD 33+
46
DLBC flow
- B cell markers - clonal
47
AMPL adverse prognostic features
- none
48
hodgkin cytogenetic abnormality
- none
49
AML peripheral smear
- blasts - Auer rods
50
acute lymphoblastic LN pattern
- diffuse
51
CML cytogenetic abnormality
- Philadelphia chromosome - t(9;22)
52
acute lymphoblastic flow
- CD4+ - CD8+
53
CML adverse prognostic features
- resistance to TKI
54
CLL cytogenetic abnormality
- no
55
acute lymphoblastic immunostain
- none
56
follicular cytogenetic abnormality
- t(14;18)
57
CLL treatment
- treat for symptoms
58
follicular curable
- no
59
SLL working formulation grade
- low
60
DBLC most diagnostic test
- flow - light microscopy - immunostain
61
CML curable
- yes
62
SLL immunostain
- none
63
SLL flow
- CD5+ - CD23+ - clonal
64
follicular LN pattern
- nodular
65
hodgkin flow
- non-clonal - non-diagnostic
66
mantle cell working formulation grade
- low and high
67
DBLC immunostain
- BCL6
68
AML cytogenetic abnormality
- no
69
hodgkin most diagnostic test
- immunostain
70
acute lymphoblastic most diagnostic test
- cytogenetics
71
APML curable
- yes
72
APML treatment
- ALTRA
73
Burkitt flow
- CD10+ - CD19+ - clonal
74
APML peripheral smear
- blasts - promyelocytes
75
Hodgkin LN pattern
- nodular with sclerosis
76
DBLC working formulation grade
- intermediate
77
hodgkin curable
- yes
78
follicular working formulation grade
- low
79
ALL cytogenetic abnormality
- no
